Arcellx (ACLX) Other Accumulated Expenses (2021 - 2025)
Arcellx (ACLX) recorded quarterly Other Accumulated Expenses of $4.4 million in Q4 2025, down 35.6% quarter-over-quarter from $6.8 million in Q3 2025, and down 48.89% on a YoY basis from $8.5 million in Q4 2024.
Arcellx (ACLX) Other Accumulated Expenses (2021 - 2025) Analysis & Trends
Arcellx's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $4.4 million for Q4 2025.
- In Q4 2025, Other Accumulated Expenses fell 48.89% year-over-year to $4.4 million; the TTM figure through Dec 2025 stood at $4.4 million (down 48.89% YoY), while the FY2025 annual figure was $4.4 million, down 48.89% from the prior year.
- Other Accumulated Expenses was $4.4 million for Q4 2025 at Arcellx, down from $6.8 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $26.9 million in Q2 2024 to a low of $164000.0 in Q1 2022.
- Historically, Other Accumulated Expenses has averaged $8.9 million across 5 years, with a median of $7.4 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses jumped 4720.12% in 2023, then plunged 72.91% in 2025.
- A 5-year view of Other Accumulated Expenses shows it stood at $1.8 million in 2021, then soared by 71.66% to $3.1 million in 2022, then jumped by 162.34% to $8.2 million in 2023, then increased by 3.86% to $8.5 million in 2024, then sank by 48.89% to $4.4 million in 2025.
- The last three Other Accumulated Expenses figures came in at $4.4 million (Q4 2025), $6.8 million (Q3 2025), and $8.5 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.36 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Jun 30, 2025 | 8.51 Mn |
| Mar 31, 2025 | 7.36 Mn |
| Dec 31, 2024 | 8.53 Mn |
| Sep 30, 2024 | 24.99 Mn |
| Jun 30, 2024 | 26.90 Mn |
| Mar 31, 2024 | 23.63 Mn |
| Dec 31, 2023 | 8.21 Mn |
| Sep 30, 2023 | 10.22 Mn |
| Jun 30, 2023 | 5.02 Mn |
| Mar 31, 2023 | 7.91 Mn |
| Dec 31, 2022 | 3.13 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 1.66 Mn |
| Mar 31, 2022 | 164,000.00 |
| Dec 31, 2021 | 1.82 Mn |